Cargando…
How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?
BACKGROUND: In Zimbabwe, while the Xpert MTB/RIF assay is being used for diagnosing tuberculosis and rifampicin-resistance, re-treatment tuberculosis (TB) patients are still expected to have culture and drug sensitivity testing (CDST) performed at national reference laboratories for confirmation. Th...
Autores principales: | Timire, Collins, Takarinda, Kudakwashe C, Harries, Anthony D, Mutunzi, Herbert, Manyame-Murwira, Barbara, Kumar, Ajay M V, Sandy, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044330/ https://www.ncbi.nlm.nih.gov/pubmed/29992299 http://dx.doi.org/10.1093/trstmh/try054 |
Ejemplares similares
-
Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey
por: Timire, Collins, et al.
Publicado: (2019) -
Prevalence, risk factors and treatment outcomes of isoniazid resistant TB in Bulawayo city, Zimbabwe: A cohort study
por: Manyame-Murwira, Barbara, et al.
Publicado: (2020) -
Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019) -
Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden
por: van Zyl-Smit, Richard N., et al.
Publicado: (2011)